CIK 0001768224 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 82.0 M | 206.0 M |
| Net income (USD) | -65.8 M | 9.3 M |
| Diluted EPS (USD/shares) | -2.4 | 0.35 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-07 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-09-23 | 8-K | 8-K items 7.01,9.01 | 2026-09-23 |
| 2026-08-25 | 8-K | 8-K items 7.01,9.01 | 2026-08-25 |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-02 | 8-K | 8-K items 1.01,7.01,9.01 | 2026-06-26 |
| 2026-06-15 | 4 | 4 | 2026-06-05 |
| 2026-06-15 | 4 | 4 | 2026-06-05 |
| 2026-06-15 | 4 | 4 | 2026-06-05 |
| 2026-06-15 | 4 | 4 | 2026-06-05 |
| 2026-06-15 | 4 | 4 | 2026-06-05 |
| 2026-06-15 | 4 | 4 | 2026-06-05 |
| 2026-06-15 | 4 | 4 | 2026-06-05 |
| 2026-06-05 | 8-K | 8-K items 5.07 | 2026-06-05 |
| 2026-05-07 | 4 | 4 | 2026-05-01 |
| 2026-05-07 | 3 | 3 | 2026-05-01 |
| 2026-05-07 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-07 | 8-K | 8-K items 2.02,5.02,7.01,9.01 | 2026-05-01 |
| 2026-05-07 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-24 | DEF 14A | DEF 14A | 2026-06-05 |
| 2026-03-26 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-03-03 | 10-K | 10-K | 2025-12-31 |
| 2026-03-03 | 8-K | 8-K items 2.02,9.01 | 2026-03-03 |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-03 | SCHEDULE 13G/A | SCHEDULE 13G/A |
Forms on file (last 1,000): 4 137, 8-K 102, SC 13G/A 24, 10-Q 22, 144 14, SCHEDULE 13G/A 13, SC 13G 13, 3 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ARCT (0.002 USD), /gw/filings/filings?ticker=ARCT&form=8-K, /gw/filings/facts?ticker=ARCT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange